Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790543 · ClinicalTrials.gov registry record
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 1,813
- Enrollment target
NCT00790543: Completed study, sponsored by Emory University.
NCT00790543 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 1,813 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00790543 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 1,813 participants
- Enrollment target
Study Summary
The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,813 participants |
| Start Date | 2008-11 |
| Est. Completion | 2020-12-31 |
What the finished NCT00790543 record still lists
NCT00790543 is an observational study that tracks outcomes without assigning an intervention. Its 1,813 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00790543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00790543 about?
NCT00790543 is a clinical study titled "Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease". The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.
What is the current status of trial NCT00790543?
This trial is currently completed. The enrollment target is 1,813 participants. The study started on 2008-11. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT00790543?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia